title: Synthesis of nitric oxide in human osteoblasts in response to physiologic stimulation of electrotherapy.
abstract: Electrotherapy for bone healing, remodeling and wound healing may be mediated by modulation of nitric oxide (NO). Using NO-specific fluorophore (DAF-2), we report here that application of non-invasive, physiologic electrical stimulation induces NO synthesis in human osteoblasts, and that such NO generation is comparable to that induced by estrogen treatment. For example, application of a sinusoidal 1 Hz, 2 V/cm (peak to peak) electrical stimulation (ES) increases NO-bound DAF-2 fluorescence intensity by a 2-fold within 60 min exposure by activating nitric oxide synthase (NOS). Increase in the NO level is found to depend critically on the frequency and strength of ES. While the frequency of 1 Hz ES seems optimal, the ES strength >0.5 V/cm is required to induce significant NO increase, however. Nitric oxide synthesis in response to ES is completely prevented by blocking estrogen receptors using a competitive inhibitor, suggesting that NO generation is likely initiated by activation of estrogen receptors at the cell surface. Based on these findings, physiologic stimulation of electrotherapy appears to represent a potential non-invasive, non-genomic, and novel physical technique that could be used to regulate NO-mediated bone density and facilitate bone remodeling without adverse effects associated with hormone therapy.
authors.affiliation: Department of Bioengineering, University of Illinois at Chicago, 851 S. Morgan St. (M/C 063), Chicago, IL, 60607, USA.
authors.forename: Ayman
authors.initials: A
authors.lastname: Hamed
authors.forename: Paul
authors.initials: P
authors.lastname: Kim
authors.forename: Michael
authors.initials: M
authors.lastname: Cho
mesh_terms: D016723:Bone Remodeling; D002478:Cells, Cultured; D004558:Electric Stimulation; D004599:Electric Stimulation Therapy; D004967:Estrogens / Q000009:adverse effects / Q000494:pharmacology; D019793:Fluorescein; D017102:Fracture Healing; D050723:Fractures, Bone / Q000378:metabolism / Q000534:rehabilitation; D020249:Hormone Replacement Therapy; D006801:Humans; D009569:Nitric Oxide / Q000096:biosynthesis*; D010006:Osteoblasts / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000096:biosynthesis; D013997:Time Factors
chemical_list: C111205:4,5-diaminofluorescein; D004967:Estrogens; D011960:Receptors, Estrogen; D009569:Nitric Oxide; D019793:Fluorescein